Neuromuscular Biobank ( Newcastle and London ) : Supporting and facilitating rare and neuromuscular disease research worldwide

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced serum myostatin concentrations associated with genetic muscle disease progression

  2017cited by this paper
• Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro

  2016cited by this paper
• The FAIR Guiding Principles for scientific data management and stewardship

  2016cited by this paper
• BBMRI-ERIC: the novel gateway to biobanks

  2016cited by this paper
• Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients

  2016cited by this paper
• Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome

  2016cited by this paper
• Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy

  2016cited by this paper
• Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy

  2015cited by this paper
• Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics

  2015cited by this paper
• BBMRI-ERIC as a resource for pharmaceutical and life science industries: the development of biobank-based Expert Centres

  2014cited by this paper
• EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia

  2014cited by this paper
• The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases

  2014influential reference
• RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research

  2014influential reference
• ANO10 mutations cause ataxia and coenzyme Q10 deficiency

  2014cited by this paper
• Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.

  2014cited by this paper
• OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders

  2014cited by this paper
• Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.

  2014cited by this paper
• Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies

  2014cited by this paper
• Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission

  2014influential reference
• Exon Skipping and Gene Transfer Restore Dystrophin Expression in Human Induced Pluripotent Stem Cells-Cardiomyocytes Harboring DMD Mutations

  2013cited by this paper
• Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy

  2013cited by this paper
• Congenital myasthenic syndromes due to mutations in ALG2 and ALG14

  2013cited by this paper
• Using International Classification of Diseases, 10th edition, codes to estimate abusive head trauma in children.

  2012cited by this paper
• Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).

  2011cited by this paper
• [Orphanet: a European database for rare diseases].

  2008cited by this paper

• Large-scale Proteomics Profiling of Peripheral Blood of DM1 patients identifies biomarkers for disease severity and functional capacity

  2025cites this paper
• MRC Centre for Neuromuscular Diseases Biobank London: its role in the advancement of rare and neuromuscular diseases research.

  2025cites this paper
• Biorepositories For Global Rare Disease Research: A Narrative Review

  2025cites this paper
• Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy.

  2023cites this paper
• Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1

  2023cites this paper
• Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review

  2023cites this paper
• Public awareness and attitudes toward biobank and sample donation: A regional Chinese survey

  2022cites this paper
• Novel insights into PORCN mutations, associated phenotypes and pathophysiological aspects

  2022cites this paper
• NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice

  2022cites this paper
• Induced pluripotent stem cell derivation from myoblasts

  2021cites this paper
• Dysregulation of GSK3β-Target Proteins in Skin Fibroblasts of Myotonic Dystrophy Type 1 (DM1) Patients

  2021cites this paper
• Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency

  2020cites this paper
• Biobanks in oncology: global experience and Russian reality

  2020cites this paper
• Protein signature of human skin fibroblasts allows the study of the molecular etiology of rare neurological diseases

  2020cites this paper
• Inhospital Complications of Patients With Neuromuscular Disorders Undergoing Total Joint Arthroplasty

  2019cites this paper
• Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort

  2019cites this paper
• Aspects of Modern Biobank Activity – Comprehensive Review

  2018cites this paper
• Myostatin and follistatin as monitoring and prognostic Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy biomarkers in dysferlinopathy

  year unknowncites this paper